retatrutide triple agonist phase 2 obesity trial ⭐️topline results from TRIUMPH-1, a 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon hormone receptor agonist, in adults with or “overweight” Lilly's triple agonist, retatrutide, delivered
Pay in 4 interest-free payments of $5.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19




























